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reserved.1. Introduction
Multi component reactions (MCRs) become powerful tools in
organic reactions to form more than one carbon–carbon or
carbon–heteroatom bond in one-pot procedures. The organicchemists are designing new synthetic methods in organic syn-
thesis that they are environmentally and economically useful
in compare with multi-step reactions which produce large
amounts of waste after each step [1].
Uracil and its derivatives, such as pyrido [2,3-d]pyrimidines
have received considerable attention over the past years
because of their several biological activities such as, antibacte-
rial [2], antiallergic [3], antimicrobial [4], tyrosine kinase [5],
anti-inﬂammatory [6], analgesic [7], calcium channel antago-
nists [8], antihypertensive [9], tuberculostatic [10], antileishma-
nial [11], and antifungal [12].
Solvent-free reaction conditions are of great interest
because they are clean, efﬁcient and reduce the use of organic
solvents [13]. Also, using heterogeneous catalysts for organic
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Figure 1 Synthesis of tetrahydropyrido[2,3-d]pyrimidine derivatives 4 in the presence of SBA-Pr-SO3H.
Table 1 The optimization of reaction conditions for the
synthesis of 4a.
Entry Solvent Condition Time (min) Yield* (%)
1 – 60 C 5 82
2 H2O Reﬂux 15 76
3 EtOH Reﬂux 125 60
4 H2O:EtOH (1:1) Reﬂux 45 50
5 CH2Cl2 Reﬂux 180 Trace
6 Acetone Reﬂux 150 47
7 – 120 C 90 <30
* Isolated yield. Reaction conditions: 6-amino uracil (1 mmol),
benzaldehyde (1 mmol), malononitrile (1 mmol), SBA-Pr-SO3H
(0.02 g).
Table 3 Synthesis of tetrahydropyrido[2,3-d]pyrimidines 4a
with recycled SBA-Pr-SO3H.
1st run 2nd run 3rd run 4th run 5th run
Time (min) 5 5 6 7 7
Yield* (%) 82 80 78 79 76
* Recycle experiments were carried out on 1 mmol reaction of 6-
amino uracil (1 mmol), benzaldehyde (1 mmol) and malononitrile
(1 mmol) in the presence of SBA-Pr-SO3H at 140 C. After each
run, the recovered catalyst can be reactivated by simple washing
subsequently with diluted acid solution, water and acetone.
One-pot synthesis of pyrido[2,3-d]pyrimidine derivatives 677transformations makes a gradual shift to more economical and
environmental synthesis [14]. These catalysts hold signiﬁcant
potential for several reasons such as, high surface area, large
pore size, excellent stability (chemical and thermal), high selec-
tivity, and easy isolation from products [15]. Sulfonic acid func-
tionalized SBA-15, as a heterogeneous solid acid catalyst, has
been applied in some one-pot syntheses [16]. Therefore, in con-
tinuation of our previous studies on the development of hetero-
geneous solid catalysts in heterocyclic synthesis [17], we used
SBA-Pr-SO3H nanoporous silica as a highly efﬁcient heteroge-
neous acid catalyst for the synthesis of pyrido [2,3-d]pyrimidine
derivatives via a three-component reaction of 6-aminouracil,
various aromatic aldehydes and malononitrile.
2. Results and discussion
2.1. Synthesis of tetrahydropyrido[2,3-d]pyrimidine derivatives
In our initial study, we describe condensation of aromatic
aldehydes 1, malononitrile 2 and 6-amino uracil 3 in the
presence of SBA-Pr-SO3H as a highly active nanoporous
heterogeneous acid catalyst for the synthesis of pyrido
[2,3-d]pyrimidine derivatives 4 (Fig. 1). At ﬁrst, we tested theTable 2 SBA-15-Pr-SO3H catalyzed the synthesis of tetrahydropyr
Entry Ar Product Time (
1 C6H5 4a 5
2 3-NO2C6H4 4b 30
3 4-OCH3C6H4 4c 45
4 4-ClC6H4 4d 20
5 4-CH3C6H4 4e 45
6 4-FC6H4 4f 30
7 2,6-Cl2C6H3 4g 40
8 2,3-(OCH3)2C6H3 4h 25
9 2,4-Cl2C6H3 4i 30reaction between 6-amino uracil, benzaldehyde and malono-
nitrile in the presence of SBA-Pr-SO3H in different solvents
to optimize the reaction conditions (Table 1). As shown in
Table 1, the best result was obtained after 5 min in solvent-free
condition at 60 C in good to excellent yield.
After optimizing the reaction conditions, we used several
aromatic aldehydes (containing electron rich or electron deﬁ-
cient substituent) for the synthesis of other derivatives in sol-
vent free condition at 60 C, as shown results in Table 2. For
all substrates, the reaction could be completed in 5–45 min
with high yields.
After completion of the reaction which was monitored by
TLC, the mixture was dissolved in hot ethanol and water,
the heterogeneous solid catalyst was removed easily by simple
ﬁltration, and after cooling of the ﬁltrate, the pure crystals of
products were obtained as mentioned in Table 2. The acid cat-
alyst can be reactivated by simple washing subsequently with
diluted acid solution, water and acetone, and then reused with-
out noticeable loss of reactivity. As shown in Table 3, the
recovered SBA-Pr-SO3H could be recycled for ﬁve times with-
out any signiﬁcant loss of yields.
A proposed mechanism for the synthesis of tetrahydropyr-
ido[2,3-d]pyrimidine derivatives 4 is shown in Fig. 2. Initially
the Knoevenagel condensation of aldehyde 1 and malononitri-
le 2 produces benzylidene malononitrile 5. Michael addition of
6-aminouracil 3 to product 5 gives the intermediate 6. SBA-Pr-ido[2,3-d]pyrimidines 4.
min) Yield (%) mp (C) mp (Lit)
82 >300 >300 [18]
86 >300 >300 [18]
75 >300 >300 [18]
80 >300 >300 [19]
78 >300 >300 [18]
78 >300 >300 [19]
69 >300 –
77 >300 –
70 >300 >300 [18]
Table 4 Comparison of different conditions in the synthesis of pyrido[2,3-d]pyrimidines 4a.
Entry Catalyst Solvent Condition Time (min) Yield (%) Year
1 – EtOH Reﬂux 4 h 88 2002 [20]
2 TEBAC H2O 90 C 10 h 97 2007 [19]
3 ZrO2 – 60 C 2 h 96 2012 [18]
4 TEOA H2O 80 C 2 h 94 2013 [21]
5 SBA-Pr-SO3H – 60 C 5 82 This Work
TEBAC: Triethylbenzylammonium chloride, TEOA: Triethanolamine.
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Figure 2 Proposed mechanism for the synthesis of tetrahydropyrido[2,3-d]pyrimidines.
678 G. Mohammadi Ziarani et al.SO3H protonates the intermediate 6 and after cyclization and
oxidation, the product 4 is produced (Fig. 2).
Synthesis of pyrido[2,3-d]pyrimidines has been reported
under different conditions in the literature, as shown in Table 4.
In contrast with other existing methods, short reaction time,
simple procedure, easy work-up and green condition are the
advantages of current methodology.
2.2. Antimicrobial activities of tetrahydropyrido[2,3-
d]pyrimidine derivatives
In our second study, we screened antimicrobial activities of
some synthesized pyrido[2,3-d]pyrimidines using the diskdiffusion method. In this research, ﬁve microorganisms were
used such as Escherichia coli ATCC 25922 and Pseudomonas
aeruginosaATCC85327 (Gram-negative bacteria),Bacillus sub-
tilisATCC 465 and Staphylococcus aureusATCC 25923 (Gram-
positive bacteria), and Candida albicans ATCC 10231 (fungi).
Pyrido[2,3-d]pyrimidines were dissolved in DMSO (100 lg/
ml), and 25 ll was loaded onto 6-mm paper disks. One hundred
micro liters of 109 cell/ml suspension of themicroorganisms was
spread on sterileMueller–Hinton agar plates, and the disks were
placed on the surface of culture plates. The inhibition zone of
compounds around the disk is shown in Table 5 which com-
pared with three commercial antibiotics such as Chloramphen-
icol, Gentamicin and Nystatin. Compounds 4a, 4d, 4e, and 4g
Table 5 Inhibition zones (mm) of synthesized pyrido[2,3-d]pyrimidines against fungi and gram positive and negative bacteria by the
disk diffusion method.
Compound B. subtilis S. aureus E. coli P. aeruginosa C. albicans
4a 28 23 0 0 14
4b 0 0 0 0 0
4c 0 0 0 0 0
4d 26 30 8 10 12
4e 28 20 9 0 10
4f 30 24 0 0 0
4g 28 18 0 0 0
4h 0 0 0 0 0
Chloramphenicol 26 22 24 8 –
Gentamicin 28 20 20 18 –
Nystatin – – – – 18
Table 6 Minimum inhibitory concentrations (lg/mL) of synthesized pyrido[2,3-d] pyrimidines against fungi and gram positive and
negative bacteria.
Compound B. subtilis S. aureus E. coli P. aeruginosa C. albicans
4a 2 8 – – 128
4b – – – – –
4c – – – – –
4d 8 2 512 512 256
4e 2 32 512 – 512
4f 2 8 – – –
4g 4 64 – – –
4h – – – – –
Chloramphenicol 4 8 4 256 –
Gentamicin 0.125 0.5 0.5 1 –
Nystatin – – – – 8
Figure 3 Preparation of SBA-Pr-SO3H and its SEM and TEM images.
One-pot synthesis of pyrido[2,3-d]pyrimidine derivatives 679display activity against B. subtilis and S. aureus. Compounds 4d
and 4g display activity against E. coli. Also compound 4d dis-
plays activity against P. aeruginosa and compounds 4a, 4d and
4e display activity against C. albicans.The minimum inhibitory concentration (MIC) of the
selected compounds which showed antibiotic activity in disk
diffusion tests was also determined by the microdilution
method [22] to compare with three commercial antibiotics:
680 G. Mohammadi Ziarani et al.Chloramphenicol, Gentamicin and Nystatin. The results are
shown in Table 6.
2.3. Synthesis and functionalization of SBA-15
According to our previous report [23], the nanoporous com-
pound SBA-15 was synthesized and functionalized (Fig. 3).
Fig. 3 also illustrated the SEM and TEM images of SBA-Pr-
SO3H. As can be seen in Fig. 3 (left), functionalized SBA-15
has uniform particles about 1 lm in SEM image which is same
as observed morphology for SBA-15. This indicates that during
the surface modiﬁcations, morphology of solid was saved with-
out signiﬁcant change. Also the TEM image of SBA-Pr-SO3H
in Fig. 3 (right) shows the parallel channels, which is similar
to the pore conﬁguration of SBA-15. It means that during
two step reactions, the pore of SBA-Pr-SO3Hwas not collapsed.
3. Experimental section
The chemicals employed in this project were obtained from
Merck Company and used with no puriﬁcations. Infrared
(IR) was recorded from KBr disk using a FT-IR Bruker Ten-
sor 27 instrument. Melting points were measured by using the
capillary tube method with an Electro thermal 9200 apparatus.
1H NMR spectra were run on a Bruker 500 MHz and
400 MHz. TMS was used as internal standard. Mass spectra
data were obtained by using Network mass selective detector
(Agilent) 6890/5973 instrument. SEM analysis of catalyst
was carried out on a Philips XL-30 ﬁeld-emission scanning
electron microscope operated at 16 kV and TEM analysis of
catalyst was performed on a Tecnai G2 F30 at 300 kV.
3.1. General procedure for the synthesis of
tetrahydropyrido[2,3-d]pyrimidine derivatives 4(a–i)
To a mixture of aromatic aldehydes 1 (1 mmol), 6-amino uracil
3 (1 mmol), and malononitrile 2 (1 mmol) was added a cata-
lytic amount of activated SBA-Pr-SO3H (0.02 g). The resulting
mixture was heated in solvent-free condition at 60 C for time
indicated in Table 2. After complication of reaction which was
monitored by TLC, the solid product was dissolved in hot eth-
anol and water (1:1). The catalyst is insoluble and could be
removed by ﬁltration. The pure products 4(a–i) were obtained
after cooling of the ﬁltrates. The physical and spectral (IR, 1H
NMR and MS) data for new compounds are given below.
7-Amino-5-(2,6-dichlorophenyl)-2,4-dioxo-1,2,3,4-tetrahy-
dropyrido[2,3-d]pyrimidine-6-carbonitrile (4g): Mp> 300 C.
IR (tmax) (KBr): 3406, 3121, 3076, 3025, 2921, 2853, 2234,
1682, 1602, 1575, 1556 cm1. 1H NMR (500 MHz, DMSO-
d6) d= 7.38 (t, J= 7.5 Hz, 1H, CH arom), 7.61 (d,
J= 8.5 Hz, 1H, CH arom), 7.69 (d, J= 8.5 Hz, 1H, CH
arom), 8.31 (br. s, 2H, NH2), 10.91 (br. s, 2H, 2NH) ppm.
MS (m/e) = 348 [M+] (10), 328 (14), 312 (32), 262 (39), 227
(71), 192 (70), 175 (67), 127 (100), 99 (57).
7-Amino-5-(2,3-dimethoxyphenyl)-2,4-dioxo-1,2,3,4-tetra-
hydropyrido[2,3-d]pyrimidine-6-carbonitrile (4h):
Mp> 300 C. IR (tmax) (KBr): 3399, 3333, 3183, 3086, 2939,
2835, 2226, 1698, 1646, 1594, 1559, 1479, 1430 cm1. 1H
NMR (400 MHz, DMSO-d6) d= 3.56 (s, 3H, CH3), 3.85 (s,
3H, CH3), 6.65 (m, 1H, CH arom), 7.087 (d, J= 4.8 Hz,
1H, CH arom), 7.088 (d, J= 4.0 Hz, 1H, CH arom), 7.64(br. s, 2H, NH2), 11.06 (br. s, 2H, 2NH) ppm. MS (m/
e) = 339 [M+] (15), 308 (44), 265 (15), 214 (49), 199 (40),
166 (44), 128 (57), 101 (92), 77 (100), 55 (88).
4. Conclusion
In conclusion, we demonstrated that SBA-15-Pr-SO3H is an
active nanoreactor catalyst in the synthesis of tetrahydropyri-
do[2,3-d]pyrimidine derivatives by one-pot condensation of
6-amino uracil, various aromatic aldehydes and malononitrile.
The advantages of this method are easy and clean work-up,
reusable catalyst, short reaction time and high efﬁciency under
solvent free conditions. Compounds 4a, 4d, 4e, and 4g display
antimicrobial activities against some fungi and gram positive
and negative bacteria.
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